AXL and cancer: Clinically, the expression of AXL has been shown to correlate with a poor prognosis and to increase metastatic risk in several tumors, where it is implicated in cancer proliferation, survival, apoptotic evasion, and invasion, as well as in the acquisition of a stem-cell phenotype and in drug resistance25.